Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. BBBY
BBBY logo

BBBY Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Bed Bath & Beyond Inc (BBBY) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
4.370
1 Day change
52 Week Range
12.650
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Bed Bath & Beyond Inc is not a good buy for a beginner, long-term investor at this time. The company is facing significant financial challenges, with declining revenue, net income, and EPS. Additionally, the technical indicators and options data do not suggest a strong bullish sentiment. While there are some signs of improvement in the core business, the risks outweigh the potential rewards for a long-term investment.

Technical Analysis

The technical indicators are mixed but lean bearish. The MACD is positive but contracting, RSI is neutral at 35.718, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The price is trading near support levels (S1: 4.618), with resistance at R1: 5.022.

Options Data

Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

The low put-call open interest ratio indicates more interest in calls, but the high option volume put-call ratio suggests bearish sentiment in recent trading.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
9
Buy
3

Positive Catalysts

  • The gross margin increased by 7.05% YoY in Q4 2025, and Wedbush sees some upside potential in topline estimates with positive website data trends.

Neutral/Negative Catalysts

  • Additionally, the stock has been downgraded by analysts, and the market sentiment appears bearish.

Financial Performance

In Q4 2025, revenue dropped to $273.43 million (-9.80% YoY), net income fell to -$20.875 million (-74.31% YoY), and EPS declined to -0.3 (-81.93% YoY). Gross margin improved to 24.6% (+7.05% YoY), but overall financial performance remains weak.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have lowered price targets recently (Piper Sandler to $8 from $10, Wedbush to $7 from $13). While there is some optimism about internal initiatives and website trends, uncertainty remains high, and analysts are cautious about the stock.

Wall Street analysts forecast BBBY stock price to rise
5 Analyst Rating
Wall Street analysts forecast BBBY stock price to rise
1 Buy
4 Hold
0 Sell
Hold
Current: 4.370
sliders
Low
8
Averages
11.67
High
17
Current: 4.370
sliders
Low
8
Averages
11.67
High
17
Piper Sandler
Neutral
downgrade
$10 -> $8
AI Analysis
2026-02-24
Reason
Piper Sandler
Price Target
$10 -> $8
AI Analysis
2026-02-24
downgrade
Neutral
Reason
Piper Sandler lowered the firm's price target on Bed Bath & Beyond to $8 from $10 and kept a Neutral rating on the shares following a Q4 print that showed sequential improvement in the core business. While revenue was still down year-over-year, internal initiatives such as SKU consolidation appear to be gaining traction, Piper notes. The firm remains on the sidelines given the amount of uncertainty in bringing its three-pillar framework together.
Wedbush
Outperform
to
NULL
downgrade
$13 -> $7
2026-02-18
Reason
Wedbush
Price Target
$13 -> $7
2026-02-18
downgrade
Outperform
to
NULL
Reason
Wedbush lowered the firm's price target on Bed Bath & Beyond to $7 from $13 to reflect a more modest EV-to-EBITDA multiple of 8 times on 2027 EBITDA estimate, while keeping an Outperform rating on the shares. Looking at Q4 results, the firm sees more upside than downside risk to topline estimates with website data trending positively during the quarter - these positive trends have persisted thus far into Q1, giving Wedbush incremental optimism that the core business is finally inflecting positive.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for BBBY
Unlock Now

People Also Watch